282 related articles for article (PubMed ID: 28237404)
21. Pharmacogenetics of immunosuppressants: State of the art and clinical implementation - recommendations from the French National Network of Pharmacogenetics (RNPGx).
Woillard JB; Chouchana L; Picard N; Loriot MA;
Therapie; 2017 Apr; 72(2):285-299. PubMed ID: 28318610
[TBL] [Abstract][Full Text] [Related]
22. Warfarin pharmacogenetics: to genotype or not to genotype, that is the question.
Cavallari LH; Nutescu EA
Clin Pharmacol Ther; 2014 Jul; 96(1):22-4. PubMed ID: 24942399
[TBL] [Abstract][Full Text] [Related]
23. [Comparison of Empiric and Pharmacogenetic Approaches in Assessment of Efficacy of Anticoagulant Therapy].
Kokh NV; Slepukhina AA; Tsvetovskaya GA; Lifshits GA
Kardiologiia; 2015; 55(4):57-60. PubMed ID: 26502504
[TBL] [Abstract][Full Text] [Related]
24. Pharmacogenomics and adverse drug reactions: the case of statins.
Giorgi MA; Caroli C; Arazi HC; Di Girolamo G
Expert Opin Pharmacother; 2011 Jul; 12(10):1499-509. PubMed ID: 21568825
[TBL] [Abstract][Full Text] [Related]
25. Clinical pharmacogenomics of warfarin and clopidogrel.
Shin J
J Pharm Pract; 2012 Aug; 25(4):428-38. PubMed ID: 22674970
[TBL] [Abstract][Full Text] [Related]
26. [Pharmacogenetics of oral anticoagulants: individualized drug treatment for more efficacy and safety].
Loriot MA; Beaune P
Rev Prat; 2007 Jun; 57(12):1281-6. PubMed ID: 17717937
[TBL] [Abstract][Full Text] [Related]
27. Effect of CYP2C9 and VKORC1 genetic polymorphisms on mean daily maintenance dose of acenocoumarol in South Indian patients.
Krishna Kumar D; Madhan S; Balachander J; Sai Chandran BV; Thamijarassy B; Adithan C
Thromb Res; 2013 Apr; 131(4):363-7. PubMed ID: 23473641
[TBL] [Abstract][Full Text] [Related]
28. Pharmacogenetics of Direct Oral Anticoagulants: A Systematic Review.
Raymond J; Imbert L; Cousin T; Duflot T; Varin R; Wils J; Lamoureux F
J Pers Med; 2021 Jan; 11(1):. PubMed ID: 33440670
[TBL] [Abstract][Full Text] [Related]
29. The pharmacogenetics of statin therapy: when the body aches, the mind will follow.
Rossi JS; McLeod HL
J Am Coll Cardiol; 2009 Oct; 54(17):1617-8. PubMed ID: 19833261
[No Abstract] [Full Text] [Related]
30. The importance of including African populations in pharmacogenetics studies of warfarin response.
Dandara C; Ndadza A; Soko N
Pharmacogenomics; 2022 Jan; 23(1):1-4. PubMed ID: 34821506
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of genetic polymorphisms of CYP2C9 and VKORC1 - implications for warfarin management and outcome in Croatian patients with acute stroke.
Supe S; Božina N; Matijević V; Bazina A; Mišmaš A; Ljevak J; Alvir D; Habek M; Poljaković Z
J Neurol Sci; 2014 Aug; 343(1-2):30-5. PubMed ID: 24974237
[TBL] [Abstract][Full Text] [Related]
32. Genetic predisposition to adverse drug reactions in the intensive care unit.
Empey PE
Crit Care Med; 2010 Jun; 38(6 Suppl):S106-16. PubMed ID: 20502164
[TBL] [Abstract][Full Text] [Related]
33. An update on efflux and uptake transporters as determinants of statin response.
Rocha KCE; Pereira BMV; Rodrigues AC
Expert Opin Drug Metab Toxicol; 2018 Jun; 14(6):613-624. PubMed ID: 29842801
[TBL] [Abstract][Full Text] [Related]
34. Pharmacogenetics of coumarinic oral anticoagulants.
Manolopoulos VG; Ragia G; Tavridou A
Pharmacogenomics; 2010 Apr; 11(4):493-6. PubMed ID: 20350128
[TBL] [Abstract][Full Text] [Related]
35. [Impact of CYP2C9 and VKORC1 polymorphism on warfarin response during initiation of therapy].
Liu Y; Zhong SL; Tan HH; Yang M; Fei HW; Yu XY; Lin SG
Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Oct; 39(10):929-35. PubMed ID: 22321278
[TBL] [Abstract][Full Text] [Related]
36. Translation of pharmacogenetics into clinically relevant testing modalities.
Baudhuin LM; Langman LJ; O'Kane DJ
Clin Pharmacol Ther; 2007 Oct; 82(4):373-6. PubMed ID: 17851577
[TBL] [Abstract][Full Text] [Related]
37. Genotype frequencies of VKORC1 and CYP2C9 in native and Mestizo populations from Mexico, potential impact for coumarin dosing.
Villegas-Torres B; Sánchez-Girón F; Jaramillo-Villafuerte K; Soberón X; Gonzalez-Covarrubias V
Gene; 2015 Mar; 558(2):235-40. PubMed ID: 25560189
[TBL] [Abstract][Full Text] [Related]
38. New oral anticoagulants vs. warfarin treatment: no need for pharmacogenomics?
Baker WL; Chamberlin KW
Clin Pharmacol Ther; 2014 Jul; 96(1):17-9. PubMed ID: 24942397
[TBL] [Abstract][Full Text] [Related]
39. Genotype-based dosage of acenocoumarol in highly-sensitive geriatric patients.
Lozano R; Franco ME; López L; Moneva JJ; Carrasco V; Pérez-Layo MA
Int J Clin Pharmacol Ther; 2015 Mar; 53(3):206-10. PubMed ID: 25669612
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetic interactions between glimepiride and rosuvastatin in healthy Korean subjects: does the
Kim CO; Oh ES; Kim H; Park MS
Drug Des Devel Ther; 2017; 11():503-512. PubMed ID: 28260863
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]